CovidSeniorV1, Main, Exploration, bibRecord, 000369

Peripheral Blood Examination Findings in SARS-CoV-2 Infection.

Identifieur interne : 000369 ( Main/Exploration ); précédent : 000368; suivant : 000370

Peripheral Blood Examination Findings in SARS-CoV-2 Infection.

Auteurs : Alia Nazarullah ; Christine Liang ; Andrew Villarreal [États-Unis] ; Russell A. Higgins ; Daniel D. Mais

Source :

American journal of clinical pathology [ 1943-7722 ] ; 2020.

RBID : pubmed:32756872

Descripteurs français

KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Anomalie de Pelger-Huët (épidémiologie), Anomalie de Pelger-Huët (étiologie), Betacoronavirus (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (immunologie), Infections à coronavirus (sang), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (immunologie), Pneumopathie virale (sang), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH).
MESH :
- immunologie : Infections à coronavirus, Pneumopathie virale.
- sang : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Anomalie de Pelger-Huët.
- étiologie : Anomalie de Pelger-Huët.
- Adulte, Adulte d'âge moyen, Betacoronavirus, Femelle, Humains, Mâle, Pandémies, Sujet âgé, Sujet âgé de 80 ans ou plus.

English descriptors

KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Betacoronavirus (MeSH), Coronavirus Infections (blood), Coronavirus Infections (complications), Coronavirus Infections (immunology), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pelger-Huet Anomaly (epidemiology), Pelger-Huet Anomaly (etiology), Pneumonia, Viral (blood), Pneumonia, Viral (complications), Pneumonia, Viral (immunology).
MESH :
- blood : Coronavirus Infections, Pneumonia, Viral.
- complications : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Pelger-Huet Anomaly.
- etiology : Pelger-Huet Anomaly.
- immunology : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, Aged, 80 and over, Betacoronavirus, Female, Humans, Male, Middle Aged, Pandemics.

Abstract

OBJECTIVES

Peripheral blood abnormalities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been fully elucidated. We report qualitative and quantitative peripheral blood findings in coronavirus disease 2019 (COVID-19) patients and compare them with a control group.

METHODS

We reviewed electronic medical records, complete blood counts, peripheral blood smears, and flow cytometry data in 12 patients with SARS-CoV-2. These were compared with 10 control patients with symptoms suspicious for SARS-CoV-2 but who tested negative.

RESULTS

No significant differences were noted in blood counts, except that absolute lymphopenia was present frequently in the control group (P < .05). Acquired Pelger-Huët anomaly (APHA) was noted in all COVID-19 cases, in most cases affecting over 5% of granulocytes. This contrasted with APHA in only 50% of control cases, affecting fewer than 5% of granulocytes in all cases (P < .05). Monolobate neutrophils were exclusive to COVID-19 cases. COVID-19 patients had greater frequency of plasmacytoid lymphocytes (P < .05). Flow cytometry data revealed absolute CD3+ T-cell count reduction in 6 of 7 patients; all of them required mechanical ventilation.

CONCLUSIONS

Lymphopenia was infrequent in our COVID-19 cohort; however, flow cytometric analysis revealed absolute T-cell count reduction in most cases. COVID-19 cases had significant APHA with monolobate neutrophils and plasmacytoid lymphocytes as compared to controls.

DOI: 10.1093/ajcp/aqaa108
PubMed: 32756872
PubMed Central: PMC7454310

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000807
to stream Main, to step Curation: 000807

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Peripheral Blood Examination Findings in SARS-CoV-2 Infection.</title>
<author><name sortKey="Nazarullah, Alia" sort="Nazarullah, Alia" uniqKey="Nazarullah A" first="Alia" last="Nazarullah">Alia Nazarullah</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liang, Christine" sort="Liang, Christine" uniqKey="Liang C" first="Christine" last="Liang">Christine Liang</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Villarreal, Andrew" sort="Villarreal, Andrew" uniqKey="Villarreal A" first="Andrew" last="Villarreal">Andrew Villarreal</name>
<affiliation wicri:level="2"><nlm:affiliation>Hematology Laboratory, University Health System, San Antonio, TX.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Hematology Laboratory, University Health System, San Antonio</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Higgins, Russell A" sort="Higgins, Russell A" uniqKey="Higgins R" first="Russell A" last="Higgins">Russell A. Higgins</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Mais, Daniel D" sort="Mais, Daniel D" uniqKey="Mais D" first="Daniel D" last="Mais">Daniel D. Mais</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32756872</idno>
<idno type="pmid">32756872</idno>
<idno type="doi">10.1093/ajcp/aqaa108</idno>
<idno type="pmc">PMC7454310</idno>
<idno type="wicri:Area/Main/Corpus">000807</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000807</idno>
<idno type="wicri:Area/Main/Curation">000807</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000807</idno>
<idno type="wicri:Area/Main/Exploration">000807</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Peripheral Blood Examination Findings in SARS-CoV-2 Infection.</title>
<author><name sortKey="Nazarullah, Alia" sort="Nazarullah, Alia" uniqKey="Nazarullah A" first="Alia" last="Nazarullah">Alia Nazarullah</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liang, Christine" sort="Liang, Christine" uniqKey="Liang C" first="Christine" last="Liang">Christine Liang</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Villarreal, Andrew" sort="Villarreal, Andrew" uniqKey="Villarreal A" first="Andrew" last="Villarreal">Andrew Villarreal</name>
<affiliation wicri:level="2"><nlm:affiliation>Hematology Laboratory, University Health System, San Antonio, TX.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Hematology Laboratory, University Health System, San Antonio</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Higgins, Russell A" sort="Higgins, Russell A" uniqKey="Higgins R" first="Russell A" last="Higgins">Russell A. Higgins</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Mais, Daniel D" sort="Mais, Daniel D" uniqKey="Mais D" first="Daniel D" last="Mais">Daniel D. Mais</name>
<affiliation><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</nlm:affiliation>
<wicri:noCountry code="subField">San Antonio</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">American journal of clinical pathology</title>
<idno type="eISSN">1943-7722</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronavirus Infections (blood)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pelger-Huet Anomaly (epidemiology)</term>
<term>Pelger-Huet Anomaly (etiology)</term>
<term>Pneumonia, Viral (blood)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Anomalie de Pelger-Huët (épidémiologie)</term>
<term>Anomalie de Pelger-Huët (étiologie)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (sang)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (sang)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Pelger-Huet Anomaly</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pelger-Huet Anomaly</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Anomalie de Pelger-Huët</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Anomalie de Pelger-Huët</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Betacoronavirus</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b>
</p>
<p>Peripheral blood abnormalities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been fully elucidated. We report qualitative and quantitative peripheral blood findings in coronavirus disease 2019 (COVID-19) patients and compare them with a control group.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>We reviewed electronic medical records, complete blood counts, peripheral blood smears, and flow cytometry data in 12 patients with SARS-CoV-2. These were compared with 10 control patients with symptoms suspicious for SARS-CoV-2 but who tested negative.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>No significant differences were noted in blood counts, except that absolute lymphopenia was present frequently in the control group (P < .05). Acquired Pelger-Huët anomaly (APHA) was noted in all COVID-19 cases, in most cases affecting over 5% of granulocytes. This contrasted with APHA in only 50% of control cases, affecting fewer than 5% of granulocytes in all cases (P < .05). Monolobate neutrophils were exclusive to COVID-19 cases. COVID-19 patients had greater frequency of plasmacytoid lymphocytes (P < .05). Flow cytometry data revealed absolute CD3+ T-cell count reduction in 6 of 7 patients; all of them required mechanical ventilation.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Lymphopenia was infrequent in our COVID-19 cohort; however, flow cytometric analysis revealed absolute T-cell count reduction in most cases. COVID-19 cases had significant APHA with monolobate neutrophils and plasmacytoid lymphocytes as compared to controls.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32756872</PMID>
<DateCompleted><Year>2020</Year>
<Month>08</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1943-7722</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>154</Volume>
<Issue>3</Issue>
<PubDate><Year>2020</Year>
<Month>08</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>American journal of clinical pathology</Title>
<ISOAbbreviation>Am J Clin Pathol</ISOAbbreviation>
</Journal>
<ArticleTitle>Peripheral Blood Examination Findings in SARS-CoV-2 Infection.</ArticleTitle>
<Pagination><MedlinePgn>319-329</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/ajcp/aqaa108</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES">Peripheral blood abnormalities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been fully elucidated. We report qualitative and quantitative peripheral blood findings in coronavirus disease 2019 (COVID-19) patients and compare them with a control group.</AbstractText>
<AbstractText Label="METHODS">We reviewed electronic medical records, complete blood counts, peripheral blood smears, and flow cytometry data in 12 patients with SARS-CoV-2. These were compared with 10 control patients with symptoms suspicious for SARS-CoV-2 but who tested negative.</AbstractText>
<AbstractText Label="RESULTS">No significant differences were noted in blood counts, except that absolute lymphopenia was present frequently in the control group (P < .05). Acquired Pelger-Huët anomaly (APHA) was noted in all COVID-19 cases, in most cases affecting over 5% of granulocytes. This contrasted with APHA in only 50% of control cases, affecting fewer than 5% of granulocytes in all cases (P < .05). Monolobate neutrophils were exclusive to COVID-19 cases. COVID-19 patients had greater frequency of plasmacytoid lymphocytes (P < .05). Flow cytometry data revealed absolute CD3+ T-cell count reduction in 6 of 7 patients; all of them required mechanical ventilation.</AbstractText>
<AbstractText Label="CONCLUSIONS">Lymphopenia was infrequent in our COVID-19 cohort; however, flow cytometric analysis revealed absolute T-cell count reduction in most cases. COVID-19 cases had significant APHA with monolobate neutrophils and plasmacytoid lymphocytes as compared to controls.</AbstractText>
<CopyrightInformation>© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nazarullah</LastName>
<ForeName>Alia</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liang</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Villarreal</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Hematology Laboratory, University Health System, San Antonio, TX.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Higgins</LastName>
<ForeName>Russell A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mais</LastName>
<ForeName>Daniel D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Am J Clin Pathol</MedlineTA>
<NlmUniqueID>0370470</NlmUniqueID>
<ISSNLinking>0002-9173</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010381" MajorTopicYN="N">Pelger-Huet Anomaly</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Coronavirus</Keyword>
<Keyword MajorTopicYN="Y">Hematologic</Keyword>
<Keyword MajorTopicYN="Y">Peripheral blood</Keyword>
<Keyword MajorTopicYN="Y">Peripheral smear</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32756872</ArticleId>
<ArticleId IdType="pii">5868306</ArticleId>
<ArticleId IdType="doi">10.1093/ajcp/aqaa108</ArticleId>
<ArticleId IdType="pmc">PMC7454310</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Br J Haematol. 2020 Jun;189(5):844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32297330</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32141570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Signal Transduct Target Ther. 2020 Mar 27;5(1):33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32296069</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 2020 Jun;95(6):E131-E134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32129508</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 2020 Jul;95(7):870-872</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32279346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Haematol. 2003 Nov;123(3):542-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14617022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2020 Jun;20(6):363-374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32346093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Pathol. 1965 Nov;44(5):494-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5846279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncogene. 2007 Feb 26;26(9):1297-305</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17322915</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2020 May 11;221(11):1762-1769</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32227123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Pathol. 2001 Nov;116(5):665-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11710682</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 2009 Feb;84(2):116-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19021122</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31978945</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Lab Haematol. 2005 Feb;27(1):15-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15686503</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2003 Dec;28(3):239-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14522061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chim Acta. 2016 Jun 1;457:46-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27034055</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 2020 Jul;95(7):834-847</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282949</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2005 Aug 1;202(3):415-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16043521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):761-770</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32228226</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101623</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32179124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hematology Am Soc Hematol Educ Program. 2012;2012:475-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23233622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chim Acta. 2010 Nov 11;411(21-22):1587-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20691170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Hematol. 2020 Aug;95(8):999-1000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32212392</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
</list>
<tree><noCountry><name sortKey="Higgins, Russell A" sort="Higgins, Russell A" uniqKey="Higgins R" first="Russell A" last="Higgins">Russell A. Higgins</name>
<name sortKey="Liang, Christine" sort="Liang, Christine" uniqKey="Liang C" first="Christine" last="Liang">Christine Liang</name>
<name sortKey="Mais, Daniel D" sort="Mais, Daniel D" uniqKey="Mais D" first="Daniel D" last="Mais">Daniel D. Mais</name>
<name sortKey="Nazarullah, Alia" sort="Nazarullah, Alia" uniqKey="Nazarullah A" first="Alia" last="Nazarullah">Alia Nazarullah</name>
</noCountry>
<country name="États-Unis"><region name="Texas"><name sortKey="Villarreal, Andrew" sort="Villarreal, Andrew" uniqKey="Villarreal A" first="Andrew" last="Villarreal">Andrew Villarreal</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000369 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000369 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidSeniorV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32756872
   |texte=   Peripheral Blood Examination Findings in SARS-CoV-2 Infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32756872" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidSeniorV1

This area was generated with Dilib version V0.6.37.
Data generation: Thu Oct 15 09:49:45 2020. Site generation: Wed Jan 27 17:10:23 2021

	Serveur d'exploration sur la COVID chez les séniors
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID chez les séniors

Peripheral Blood Examination Findings in SARS-CoV-2 Infection.

Peripheral Blood Examination Findings in SARS-CoV-2 Infection.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki